Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

16,000

Employees16,000

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

16,000

Employees16,000

EW Key Statistics

Market cap

53.74B

Market cap53.74B

Price-Earnings ratio

54.60

Price-Earnings ratio54.60

Dividend yield

—

Dividend yield—

Average volume

4.22M

Average volume4.22M

High today

$95.75

High today$95.75

Low today

$87.93

Low today$87.93

Open price

$93.33

Open price$93.33

Volume

12.04M

Volume12.04M

52 Week high

$96.29

52 Week high$96.29

52 Week low

$74.66

52 Week low$74.66

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $93.26, with a market capitalization of 53.74B. The stock trades at a price-to-earnings (P/E) ratio of 54.60.

During the trading session on 2026-11-03, Edwards Lifesciences(EW) shares reached a daily high of $95.75 and a low of $87.93. At a current price of $93.26, the stock is +6.1% higher than the low and still -2.6% under the high.

Trading activity shows a volume of 12.04M, compared to an average daily volume of 4.22M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $96.29 and a low of $74.66.

EW News

TipRanks 3h

Edwards Lifesciences: PROGRESS Trial Supports TAVR Expansion in Selected Moderate Aortic Stenosis Patients

Edwards Lifesciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis Steed from Bank of America Securities main...

MarketWatch 8h

Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

...

Simply Wall St 1d

Is FDA Valve Repair Approval Altering The Investment Case For Edwards Lifesciences?

Edwards Lifesciences recently secured FDA approval for its PASCAL Precision system for tricuspid valve repair and the PASCAL Ace with Capture Clarity system for...

Analyst ratings

74%

of 27 ratings

Buy

74.1%

Hold

25.9%

Sell

More EW News

Simply Wall St 4d

Edwards Lifesciences Could Be 6% Undervalued As FDA Approvals Lift Growth Hopes

Advertisement FDA approvals put Edwards Lifesciences in focus Edwards Lifesciences (EW) is back on investor radars after the FDA cleared its PASCAL Precision...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.